BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Guion-Dusserre JF, Bertaut A, Ghiringhelli F, Vincent J, Quipourt V, Marilier S, Tharin Z, Bengrine-Lefevre L. Folfirinox in elderly patients with pancreatic or colorectal cancer-tolerance and efficacy. World J Gastroenterol 2016; 22(42): 9378-9386 [PMID: 27895425 DOI: 10.3748/wjg.v22.i42.9378]
URL: https://www.wjgnet.com/1007-9327/full/v22/i42/9378.htm
Number Citing Articles
1
Gwenalyn Garcia, Marcel Odaimi. Systemic Combination Chemotherapy in Elderly Pancreatic Cancer: a ReviewJournal of Gastrointestinal Cancer 2017; 48(2): 121 doi: 10.1007/s12029-017-9930-0
2
T. Macarulla, A. Carrato, R. Díaz, A. García, B. Laquente, J. Sastre, R. Álvarez, A. Muñoz, M. Hidalgo. Management and supportive treatment of frail patients with metastatic pancreatic cancerJournal of Geriatric Oncology 2019; 10(3): 398 doi: 10.1016/j.jgo.2018.06.005
3
Maya N. White, Efrat Dotan, Paul J. Catalano, Dana B. Cardin, Jordan D. Berlin. Advanced pancreatic cancer clinical trials: The continued underrepresentation of older patientsJournal of Geriatric Oncology 2019; 10(4): 540 doi: 10.1016/j.jgo.2018.11.001
4
Josenon Gomes Costa, Victor Hugo Fonseca de Jesus, Marcos Pedro Guedes Camandaroba, Aldo Lourenço Abbade Dettino. Characteristics and survival of older patients with metastatic pancreatic cancer: a retrospective analysis of the AC Camargo Cancer Center experienceTherapeutic Advances in Medical Oncology 2019; 11: 175883591987465 doi: 10.1177/1758835919874650
5
Heng‐Chung Kung, Jun Yu. Targeted therapy for pancreatic ductal adenocarcinoma: Mechanisms and clinical studyMedComm 2023; 4(2) doi: 10.1002/mco2.216
6
Grigorios Kotronoulas. Benefits, Challenges, and Opportunities of Integrating Patient-Reported Outcome Measures in Geriatric Oncology to Advance Patient Screening for Functional Fitness for TreatmentSeminars in Oncology Nursing 2021; 37(6): 151230 doi: 10.1016/j.soncn.2021.151230
7
M. Sh. Manukyan, I. S. Bazin, A. A. Tryakin. Chemotherapy for advanced pancreatic cancer in older patients (literature review)Pelvic Surgery and Oncology 2022; 12(3): 51 doi: 10.17650/2686-9594-2022-12-3-51-55
8
Stéphane Gerard, Zara Steinmeyer, Stéphanie Lozano, Marie Garric, Philippe Girard, Loic Mourey, Marion Deslandres, Gabor Abellan Van Kan, Laurent Balardy. Geriatric Oncology2020; : 245 doi: 10.1007/978-3-319-57415-8_61
9
Caterina Vivaldi, Francesca Salani, Giulia Rovesti, Irene Pecora, Silvia Catanese, Andrea Casadei-Gardini, Valentina Massa, Laura Bernardini, Laura Riggi, Kalliopi Andrikou, Giovanni I. Rapposelli, Vincenzo Formica, Monica Lencioni, Alfredo Falcone, Enrico Vasile, Lorenzo Fornaro. First-line gemcitabine plus nab-paclitaxel for elderly patients with metastatic pancreatic cancer: Crossing the frontier of age?European Journal of Cancer 2020; 137: 108 doi: 10.1016/j.ejca.2020.06.031
10
Louise André, Gabriel Antherieu, Amélie Boinet, Judith Bret, Thomas Gilbert, Rabia Boulahssass, Claire Falandry. Oncological Treatment-Related Fatigue in Oncogeriatrics: A Scoping ReviewCancers 2022; 14(10): 2470 doi: 10.3390/cancers14102470
11
Hao Xie, Junjia Liu, John R. Ogden, Jun Yin, Aminah Jatoi, Joleen M. Hubbard, Robert R. McWilliams, Amit Mahipal, Gloria M. Petersen, Tanios S. Bekaii-Saab, Wen Wee Ma. Survival Benefit of Combination Chemotherapy in Elderly Patients With Metastatic Pancreatic Ductal AdenocarcinomaAmerican Journal of Clinical Oncology 2020; 43(8): 586 doi: 10.1097/COC.0000000000000708
12
Erin N. McAndrew, Hanbo Zhang, Pascal Lambert, Rebekah Rittberg, David E. Dawe, Christina A. Kim. Treatment Patterns, Toxicity, and Outcomes of Older Adults With Advanced Pancreatic Cancer Receiving First-line Palliative ChemotherapyAmerican Journal of Clinical Oncology 2022; 45(2): 55 doi: 10.1097/COC.0000000000000882
13
Timothy N. O'Brien, Armin Shahrokni, Anne M. Horgan. Total Neoadjuvant Therapy for rectal cancer: Totally Not Translatable to the older patient?Journal of Geriatric Oncology 2023; 14(1): 101348 doi: 10.1016/j.jgo.2022.07.008
14
May Tun Saung, Lei Zheng. Current Standards of Chemotherapy for Pancreatic CancerClinical Therapeutics 2017; 39(11): 2125 doi: 10.1016/j.clinthera.2017.08.015
15
FOLFIRINOX Adjuvant Therapy for Pancreatic CancerNew England Journal of Medicine 2019; 380(12): 1187 doi: 10.1056/NEJMc1900712
16
Marloes Zoetemelk, George M. Ramzy, Magdalena Rausch, Patrycja Nowak-Sliwinska. Drug-Drug Interactions of Irinotecan, 5-Fluorouracil, Folinic Acid and Oxaliplatin and Its Activity in Colorectal Carcinoma TreatmentMolecules 2020; 25(11): 2614 doi: 10.3390/molecules25112614
17
Marina Macchini, Marta Chiaravalli, Silvia Zanon, Umberto Peretti, Elena Mazza, Luca Gianni, Michele Reni. Chemotherapy in elderly patients with pancreatic cancer: Efficacy, feasibility and future perspectivesCancer Treatment Reviews 2019; 72: 1 doi: 10.1016/j.ctrv.2018.10.013
18
Christian Schulz, Kerstin Schütte. Geriatrische gastrointestinale Onkologie: Leber, Galle, PankreasDer Gastroenterologe 2021; 16(5): 378 doi: 10.1007/s11377-021-00549-9
19
Laure Deyme, Dominique Barbolosi, Florence Gattacceca. Population pharmacokinetics of FOLFIRINOX: a review of studies and parametersCancer Chemotherapy and Pharmacology 2019; 83(1): 27 doi: 10.1007/s00280-018-3722-5
20
Lynda R. Corrigan, Dara M. Bracken-Clarke, Anne M. Horgan. The challenge of treating older patients with pancreaticobiliary malignanciesCurrent Problems in Cancer 2018; 42(1): 59 doi: 10.1016/j.currproblcancer.2018.01.015
21
Alison Lewis, Adnan Nagrial. Systematic Review of Single-Agent vs. Multi-Agent Chemotherapy for Advanced Pancreatic Adenocarcinoma in Elderly vs. Younger PatientsCancers 2023; 15(8): 2289 doi: 10.3390/cancers15082289
22
Giuseppe Colloca. Performance status as prognostic factor in phase III trials of first‐line chemotherapy of unresectable or metastatic pancreatic cancer: A trial‐level meta‐analysisAsia-Pacific Journal of Clinical Oncology 2022; 18(3): 232 doi: 10.1111/ajco.13598
23
L.J.H. Brada, M.S. Walma, R.M. van Dam, J. de Vos-Geelen, I.H. de Hingh, G.J. Creemers, M.S. Liem, L.J. Mekenkamp, V.E. de Meijer, D.J.A. de Groot, G.A. Patijn, J.W.B. de Groot, S. Festen, E.D. Kerver, M.W.J. Stommel, M.R. Meijerink, K. Bosscha, J.F. Pruijt, M.B. Polée, J.A. Ropela, G.A. Cirkel, M. Los, J.W. Wilmink, N. Haj Mohammad, H.C. van Santvoort, M.G. Besselink, I.Q. Molenaar. The treatment and survival of elderly patients with locally advanced pancreatic cancer: A post-hoc analysis of a multicenter registryPancreatology 2021; 21(1): 163 doi: 10.1016/j.pan.2020.11.012
24
Xiang Li, Da-bing Huang, Qi Zhang, Cheng-xiang Guo, Qi-han Fu, Xiao-chen Zhang, Tian-Yu Tang, Wei Su, Yi-Wen Chen, Wei Chen, Tao Ma, Shun-Liang Gao, Ri-Sheng Que, Xue-Li Bai, Ting-Bo Liang. The efficacy and toxicity of chemotherapy in the elderly with advanced pancreatic cancerPancreatology 2020; 20(1): 95 doi: 10.1016/j.pan.2019.11.012
25
Alberto Servetto, Antonio Santaniello, Fabiana Napolitano, Francesca Foschini, Roberta Marciano, Eleonora Mozzillo, Priscilla Cascetta, Anna Rita Amato, Maria Rosaria Augurio, Lucia Maresca, Pietro De Placido, Sabino De Placido, Luigi Formisano, Roberto Bianco. Use of FOLFIRINOX or Nab-Paclitaxel Plus Gemcitabine for the Treatment of Locally Advanced Pancreatic Adenocarcinoma: A Single Institution Observational StudyCancers 2021; 13(19): 4939 doi: 10.3390/cancers13194939
26
Satoshi Kobayashi, Makoto Ueno, Hiroshi Ishii, Junji Furuse. Management of elderly patients with unresectable pancreatic cancerJapanese Journal of Clinical Oncology 2022;  doi: 10.1093/jjco/hyac101
27
Anabela Barros, Catarina Pulido, Manuela Machado, Maria Brito, Nuno Couto, Olga Sousa, Sónia Melo, Hélder Mansinho. Treatment optimization of locally advanced and metastatic pancreatic cancer (Review)International Journal of Oncology 2021; 59(6) doi: 10.3892/ijo.2021.5290
28
Jennifer L. Olson, Richard J. Bold. Currently available first-line drug therapies for treating pancreatic cancerExpert Opinion on Pharmacotherapy 2018; 19(17): 1927 doi: 10.1080/14656566.2018.1509954
29
Arthur Winer, Efrat Dotan. Treatment Paradigms for Older Adults with Pancreatic Cancer: a Nuanced ApproachCurrent Treatment Options in Oncology 2021; 22(11) doi: 10.1007/s11864-021-00892-7
30
Stéphane Gerard, Zara Steinmeyer, Stéphanie Lozano, Marie Garric, Philippe Girard, Loic Mourey, Marion Deslandres, Gabor Abellan Van Kan, Laurent Balardy. Geriatric Oncology2019; : 1 doi: 10.1007/978-3-319-44870-1_61-1
31
Kazuma Daiku, Kenji Ikezawa, Toshitaka Morishima, Yugo Kai, Ryoji Takada, Takuo Yamai, Isao Miyashiro, Kazuyoshi Ohkawa. Chemotherapy effectiveness and age-group analysis of older adult patients with metastatic pancreatic cancer: A Japanese cancer registry cohort studyJournal of Geriatric Oncology 2022; 13(8): 1208 doi: 10.1016/j.jgo.2022.07.010
32
Marina Macchini, Marta Chiaravalli, Chiara Pircher, Silvia Zanon, Umberto Peretti, Elena Mazza, Maria Maddalena Valente, Clara Fugazza, Luca Gianni, Michele Reni. Multidrug regimens for treatment of older patients with metastatic pancreatic cancerDigestive and Liver Disease 2021; 53(1): 117 doi: 10.1016/j.dld.2020.06.006
33
Caspar Franck, Christian Müller, Rosa Rosania, Roland S. Croner, Maciej Pech, Marino Venerito. Advanced Pancreatic Ductal Adenocarcinoma: Moving ForwardCancers 2020; 12(7): 1955 doi: 10.3390/cancers12071955